
Huakang
8622.HKHuakang Biomedical Holdings Company Limited Price (8622.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
415,962,411
(2.7984)%Description
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.08-0.41
- Market Cap 152.64M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - Specialty & Generic
- ceo: Mr. Chunguang Zhang
- IPO Date: December, 13, 2018
- Country: HK
- Currency: HKD
- Headquaters: No Data
- Employees: 90
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
